25
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients

Pages 11-18 | Published online: 08 Jul 2009

REFERENCES

  • Ando Y, Nyhlin N, Suhr 0, Holmgren G, Uchida K, El Salhy M, Yamashita T, Tarasaki H, Nakamura M, Uchino M, Ando M. Oxidative stress is found in amyloid deposits. Biochem Biophys Res Commun 1997; 232: 497–502.
  • Ando Y, Brännström T, Uchida K, Nyhlin N, Näsman B, Suhr 0, Yamashida T, Olsson T, El Salhy M, Uchino M, Ando M. Histochemical detection of 4-hydroxynonenal protein in Alzhei-mer amyloid. J Neurol Sci 1998; 156: 172–6.
  • Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995; 1247: 12–6.
  • Suhr OB, Ando Y, Ohlsson P-I, Olofsson A, Andersson K, Lundgren E, Ando M. Investiga-tion into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Eur J Clin Invest 1998; 28: 687–92.
  • Suhr OB, Svendsen IH, Ohlsson PI, Lendoire J, Trigo P, Tashima K, Ranlov PJ, Ando Y. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloi-dosis. Amyloid 1999; 6: 187–91.
  • Butterfield DA, Koppal T, Subramaniam R, Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal mem-branes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev Neurosci 1999; 10: 141–9.
  • Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal U. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336: 1216–22.
  • Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880— 88.
  • Holmgren G, Steen L, Ekstedt J, Groth C-G, Ericzon B-G, Eriksson S, Andersson O, Karlberg I, Norden G, Nakazato M, Hawhins P, Richardson S, Pepys M. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-Met30). Clin Genet 1991; 40: 242–6.
  • Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr 0, Andersen 0, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys M. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amy-loidosis. Lancet 1993; 341: 1113–6.
  • Parilla P, Ramirez P, Bueno F, Robles R, Acosta F, Miras M, Pons J, Andreu L, Munar-Ques M. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Sur 1995; 82: 825–8.
  • Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60: 933–8.
  • Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neu-rology 1996; 47: 944–51.
  • Parra T, de Arriba G, Conejo JR, Cantero M, Arribas I, Rodriguez-Puyol D, Rodriguez-Puyol M, Carballo F. Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity. Transplantation 1998; 66: 1325–9.
  • McGrath LT, Treacy R, McClean E, Brown JH. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin Chim Acta 1997; 264: 1–12.
  • Suleymanlar G, Suleymanlar I, Shapiro JI, Chan L. Possible role of lipid peroxidation in cyclos-porine nephrotoxicity in rats. Transplant Proc 1994; 26: 2888–9.
  • Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P, Houy S, Trommer WE, Cordier A. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997; 280: 1328— 34.
  • Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxida-tive damage. Am J Clin Nutr 1991; 54: 1113S–8S.
  • Nyyssonen K, Porkkala-Sarataho E, Kaikkonen J, Salonen JT. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis 1997; 130: 223–33.
  • Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiolo-gical and clinical trial data. Pharmacol Res 1999; 40: 227–38.
  • Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Munoz-Patino AM, Labandeira-Garcia JL. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some anti-oxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 2000; 74: 1605–12.
  • Hirota M, Inoue M, Ando Y, Hirayama K, Morino Y, Sakamoto K, Mori K, Akagi M. Inhibition of stress-induced gastric injury in the rat by glutathione. Gastroenterology 1989; 97: 853–9.
  • Nyhlin N, El-Salhy M, Sandstr6m 0, Suhr 0. Evaluation of immunohistochemical staining of human duodenal endocrine cells after microwave antigen retrieval. Histochem J 1997; 29: 177–81.
  • Weibel E, Elias H. Introduction to stereologic principles. In: Weibel E, Elisas H, editors. Quantitative methods in morphology. Berlin: Springer-Verlag, 1967: 89–98
  • Weibel E, Stäubli R, Hess F. Correlated morpho-metric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol 1969; 42: 68–91.
  • El-Salhy M, Sandstr6m 0, Näsström E, Mustabbasic M, Zachrisson S. Application of computer image analysis in endocrine cell quanti-fication. Histochem J 1997; 29: 249–55.
  • Steen L, Ek B. Familial amyloidosis with poly-neuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symp-toms. Acta Med Scand 1984; 214: 387–97.
  • Suhr 0, Danielsson Aring, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloi-dotic polyneuropathy. J Intern Med 1994; 235: 479— 85.
  • Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, Yamashita T, Ando E, Uchino M, Ando M. Outcome of liver transplan-tation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 1999; 171: 19–23.
  • Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, Butterfield DA. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxyno-nenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem Res 1998; 23: 1403–10.
  • Pike CJ, Ramezan-Arab N, Cotman CW. Beta amyloid neurotoxicity in vitro: evidence of oxida-tive stress but not protection by antioxidants. J Neurochem 1997; 69: 1601–11.
  • Kugiyama K, Motoyama T, Hirashima 0, Ohgushi M, Soejima H, Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Yasue H. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 103–9.
  • Valkonen MM, Kuusi T. Vitamin C prevents the acute atherogenic effects of passive smoking. Free Radic Biol Med 2000; 28: 428–36.
  • Rydh A, Suhr 0, Hietala S-0, Riklund Ahlström K, Pepys M, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloidostic polyneuropathy: regression of visceral amyloid following transplantation. Eur J Nucl Med 1998; 25: 709–13.
  • Andersson K, Goldsteins G, Lundgren E. Trans-thyretin mutants exert cytotoxity during amyloid formation. In: VIII International Symposium on Amyloidosis. Mayo Clinic, Rochester, MN: Mayo Press, 1998

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.